NRXS Stock Analysis: Buy, Sell, or Hold?
NRXS - Neuraxis, Inc.
$6.80
-0.21 (-3.00%)
▼
5d:
+0.74%
30d:
+0.0%
90d:
-8.72%
HOLD
MODERATE Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
15d
Get Alerted When NRXS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRXS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NRXS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NRXS is currently trading at $6.80, which is considered oversold relative to its 30-day fair value range of $6.85 to $7.18.
Technical Outlook: Technically, NRXS is showing sideways momentum. Immediate support is located at $6.59, while resistance sits at $7.30.
Market Sentiment: NRXS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.00 (+61.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRXS is showing sideways momentum. Immediate support is located at $6.59, while resistance sits at $7.30.
Market Sentiment: NRXS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $11.00 (+61.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.85 -
$7.18
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.8% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$6.85 -
$7.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.60
Resistance Level
$7.30
Current Trend
Sideways
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-113.33
Wall Street Target
$11.00
(+61.8%)
Revenue Growth (YoY)
79.5%
Profit Margin
-170.1%
Share & Embed Analysis
Last updated: July 26, 2026 12:50 AM ET
Data refreshes hourly during market hours. Next update: 1:50 AM
Data refreshes hourly during market hours. Next update: 1:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXS showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian Allen Carrico
BUY
8060 shares
2026-04-01
Thomas Joeseph Carrico
BUY
667 shares
2026-04-01
Timothy Robert Henrichs
BUY
7593 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 54 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 52 HOLD |
